HCW9302

Interleukin-2 fusion protein · HCW Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCW9302, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata [Phase 1]